Matthew B. Klein, Director: ClearPoint Neuro CLPT Planned sale · Filed 05/21

Trade details

Type: Planned sale notice
Stock: ClearPoint Neuro CLPT
Person: Matthew B. KleinDirector
Planned sale date: 26/05/21
Filed: 26/05/21

$185.4K to be sold

ClearPoint Neuro trades, last 26 weeks

What else happened in ClearPoint Neuro around then

Filed or reported within 30 days of the trade day · 04/21~06/20

Matthew B. Klein's recent trades

Matthew B. KleinOfficer, Director
Planned salePTC Therapeutics
Planned sale
PTC Therapeutics
PTCT
$705.8K
10,292 sh
$705.8K
Filed 08/04
Traded 08/04
Matthew B. KleinDirector
SellClearPoint Neuro
Sell
ClearPoint Neuro
CLPT
$185.4K
16,000 sh
$185.4K
Filed 05/26
Traded 05/21
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$527.7K
7,221 sh
$527.7K
Filed 05/15
Traded 05/14
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$186.4K
2,572 sh
$186.4K
Filed 05/15
Traded 05/14
Matthew B. KleinCEO
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$153.5K
2,100 sh
$153.5K
Filed 05/15
Traded 05/14

Matthew B. Klein, Director — plans to sell 16,000 sh of ClearPoint Neuro CLPT · $185.4K · around 05/21 | Whalegun